or Try an Advanced Search...

    Technical Analysis for TTI - Thiogenesis Therapeutics, Corp

    Grade Last Price % Change Price Change
    D 0.630 -7.35% -0.050
    TTI closed down 7.35 percent on Friday, November 22, 2024, on 14 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical TTI trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    Stochastic Sell Signal Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Weak + Overbought Other 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    New Downtrend Bearish -7.35%
    50 DMA Support Bullish -7.35%
    Overbought Stochastic Strength -7.35%
    Older End-of-Day Signals for TTI ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR 3 days ago
    Down 5% 3 days ago
    Down 3% 3 days ago
    Down 2% 3 days ago
    Down 1% 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TTI Chart by TradingView
    Basic chart:

    Profile

    Thiogenesis Therapeutics, Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of a range of unmet genetic and central nervous system diseases. Its lead product candidate under development is TTI-0102, a prodrug consisting of cysteamine and pantetheine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke. The company is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Stroke

    Is TTI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 5 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.06
    52 Week Low 0.52
    Average Volume 24,487
    200-Day Moving Average 0.738
    50-Day Moving Average 0.668
    20-Day Moving Average 0.619
    10-Day Moving Average 0.620
    Average True Range 0.029
    RSI (14) 48.98
    ADX 36.0
    +DI 28.328
    -DI 39.679
    Chandelier Exit (Long, 3 ATRs) 0.604
    Chandelier Exit (Short, 3 ATRs) 0.606
    Upper Bollinger Bands 0.691
    Lower Bollinger Band 0.546
    Percent B (%b) 0.58
    BandWidth 23.432
    MACD Line -0.005
    MACD Signal Line -0.015
    MACD Histogram 0.0109
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.630
    Resistance 3 (R3) 0.630 0.630 0.630
    Resistance 2 (R2) 0.630 0.630 0.630 0.630
    Resistance 1 (R1) 0.630 0.630 0.630 0.630 0.630
    Pivot Point 0.630 0.630 0.630 0.630 0.630
    Support 1 (S1) 0.630 0.630 0.630 0.630 0.630
    Support 2 (S2) 0.630 0.630 0.630 0.630
    Support 3 (S3) 0.630 0.630 0.630
    Support 4 (S4) 0.630